J Clin Invest. 2014 May;124(5):1893-5. doi: 10.1172/JCI75241. Epub 2014 Apr 17.
The increase in immunosuppressed patient populations has correlated with a rise in clinical fungal infections, including cryptococcosis. Patient outcome following Cryptococcus infection is linked to initial fungal burden in cerebrospinal fluid (CSF) and fungal clearance following treatment; however, the role of the pathogen in disease prognosis is poorly defined. In this issue of the JCI, Sabiiti and colleagues have directly correlated phenotypic traits of Cryptococcus neoformans with clinical outcome of infected patients. A better understanding of both the host and pathogen contributions to disease etiology will provide more options for targeted treatment strategies.
免疫抑制患者人群的增加与临床真菌感染(包括隐球菌病)的上升相关。患者感染隐球菌后的转归与初始脑脊液(CSF)中真菌负荷以及治疗后真菌清除有关;然而,病原体在疾病预后中的作用尚不清楚。在本期 JCI 中,Sabiiti 及其同事直接将新型隐球菌的表型特征与感染患者的临床转归相关联。更好地了解宿主和病原体对疾病病因的贡献将为靶向治疗策略提供更多选择。